Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.

By Kyle E. Rusthoven, B. Kavanagh, H. Cardenes, V. Stieber, S. Burri, S. Feigenberg, M. Chidel, T. Pugh, W. Franklin, M. Kane and 2 more. Journal of Clinical Oncology, 2009

635 citations recorded by the source corpus.

Subfields: Hepatology, Radiation, Surgery

View Paper: https://www.semanticscholar.org/paper/f0f0d3e20f23dbb8079f634c2142e77222874b57

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Iyengar
2. Z. Wardak
3. D. Gerber
4. V. Tumati
5. C. Ahn
6. H. Choy
7. N. Cheedella
8. J. Dowell

Citations in the corpus

• Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial (2018, methodology): “Multiple meta-analyses, single-institution observational studies, retrospectiveexperiences, and limitedsinglearm prospective trials suggest that local therapy in the limited metastatic disease state for NSCLC may augment survival.(17-27)Finally, a recent phase 2 randomized study(28) includingpatient”